U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06841250) titled 'Early Changes in OCT Biomarkers After the First Intravitreal Anti-VEGF Injection in Treatment-naive DME' on Feb. 18.
Brief Summary: A retrospective, observational, hospital-based study which will be conducted in the Department of Ophthalmology, Sohag University Hospital, Egypt.
Study Start Date: Jan. 16
Study Type: OBSERVATIONAL
Condition:
Early OCT Biomarker Changes in Response to Anti-VEGF
Intervention:
PROCEDURE: intravitreal injection of anti-VEGF
Ranibizumab is injected into the vitreous under aseptic conditions as part of routine DME treatment
Recruitment Status: ENROLLING_BY_INVITATION
Sponsor: Sohag University
Info...